New York City-based pharmaceutical company, Pfizer Inc. of Pfizer is confident that its COVID-19 vaccine candidate has a huge chance to be proved effective in the clinical trial, as per Reuters that saw the internal documents of the company.
A few weeks back, the company shared a view that the effectiveness and safety of the vaccine, which is currently developed together with Germany’s BioNTech SE, would be confirmed by the end of October.Pfizer already submitted a protocol to the United States (US) Food and Drug Administration (FDA) for the vaccine review and an independent panel of experts known as a Data and Safety Monitoring Board would examine the protocol.
Read more on toopanda.com